Detalles de la búsqueda
1.
Prevalence and Burden of Illness of Rome IV Irritable Bowel Syndrome in the United States: Results From a Nationwide Cross-Sectional Study.
Gastroenterology
; 165(6): 1475-1487, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37595647
2.
Prevalence and Burden of Illness of Rome IV Chronic Idiopathic Constipation, Opioid-Induced Constipation, and Opioid-Exacerbated Constipation in the United States.
Am J Gastroenterol
; 118(11): 2033-2040, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37335135
3.
Linaclotide Attenuates Visceral Organ Crosstalk: Role of Guanylate Cyclase-C Activation in Reversing Bladder-Colon Cross-Sensitization.
J Pharmacol Exp Ther
; 366(2): 274-281, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29784661
4.
Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation.
J Pharmacol Exp Ther
; 344(1): 196-206, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23090647
5.
Efficiency of perchlorate consumption in road flares, propellants and explosives.
J Environ Manage
; 90(11): 3629-34, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19643526
6.
Discovery and Characterization of a Potent Interleukin-6 Binding Peptide with Neutralizing Activity In Vivo.
PLoS One
; 10(11): e0141330, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26555695
Resultados
1 -
6
de 6
1
Próxima >
>>